4.6 Review

DRD2: Bridging the Genome and Ingestive Behavior

期刊

TRENDS IN COGNITIVE SCIENCES
卷 21, 期 5, 页码 372-384

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tics.2017.03.004

关键词

-

向作者/读者索取更多资源

Recent work highlights the importance of genetic variants that influence brain structure and function in conferring risk for polygenic obesity. The neurotransmitter dopamine (DA) has a pivotal role in energy balance by integrating metabolic signals with circuits supporting cognitive, perceptual, and appetitive functions that guide feeding. It has also been established that diet and obesity alter DA signaling, leading to compulsive-like feeding and neurocognitive impairments. This raises the possibility that genetic variants that influence DA signaling and adaptation confer risk for overeating and cognitive decline. Here, we consider the role of two common gene variants, FTO and TaqIA rs1800497 in driving gene x environment interactions promoting obesity, metabolic dysfunction, and cognitive change via their influence on DA receptor subtype 2 (DRD2) signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Sonic Hedgehog receptor Patched deficiency in astrocytes enhances glucose metabolism in mice

Linda Tirou, Mariagiovanna Russo, Helene Faure, Giuliana Pellegrino, Clement Demongin, Mathieu Daynac, Ariane Sharif, Jeremy Amosse, Soazig Le Lay, Raphael Denis, Serge Luquet, Mohammed Taouis, Yacir Benomar, Martial Ruat

Summary: This study reveals that activation of the Shh signaling pathway in hypothalamic astrocytes enhances insulin responsiveness, impacting energy metabolism and leading to alterations in body weight and adipose tissues. It also suggests that this signaling pathway may play a crucial role in preventing age- and obesity-related metabolic disorders.

MOLECULAR METABOLISM (2021)

Article Multidisciplinary Sciences

Cardiolipin content controls mitochondrial coupling and energetic efficiency in muscle

Alexandre Prola, Jordan Blondelle, Aymeline Vandestienne, Jerome Piquereau, Raphael G. P. Denis, Stephane Guyot, Hadrien Chauvin, Arnaud Mourier, Marie Maurer, Celine Henry, Nahed Khadhraoui, Cindy Gallerne, Thibaut Molinie, Guillaume Courtin, Laurent Guillaud, Melanie Gressette, Audrey Solgadi, Florent Dumont, Julien Castel, Julien Ternacle, Jean Demarquoy, Alexandra Malgoyre, Nathalie Koulmann, Genevieve Derumeaux, Marie-France Giraud, Frederic Joubert, Vladimir Veksler, Serge Luquet, Frederic Relaix, Laurent Tiret, Fanny Pilot-Storck

Summary: Mice deficient for a muscle-specific enzyme of very-long-chain fatty acid synthesis displayed increased basal energy expenditure and protection against high-fat diet-induced obesity. Muscle-specific modulation of the very-long-chain fatty acid pathway was associated with a reduced content of inner mitochondrial membrane phospholipid cardiolipin and a blunted coupling efficiency between the respiratory chain and ATP synthase, which was restored by cardiolipin enrichment. Selective increase of lipid oxidative capacities in skeletal muscle, through the cardiolipin-dependent lowering of mitochondrial ATP production, provides an effective option against obesity at the whole-body level.

SCIENCE ADVANCES (2021)

Letter Cell Biology

Further Evidence that Habitual Consumption of Sucralose with, but Not without, Carbohydrate Alters Glucose Metabolism

Jelle R. Dalenberg, Raphael Denis, Serge Luquet, Dana M. Small

CELL METABOLISM (2021)

Review Endocrinology & Metabolism

The melanocortin pathway and energy homeostasis: From discovery to obesity therapy

Giles S. H. Yeo, Daniela Herrera Moro Chao, Anna-Maria Siegert, Zoe M. Koerperich, Mark D. Ericson, Stephanie E. Simonds, Courtney M. Larson, Serge Luquet, Iain Clarke, Shubh Sharma, Karine Clement, Michael A. Cowley, Carrie Haskell-Luevano, Lex Van der Ploeg, Roger A. H. Adan

Summary: Insights from human and mouse genetics have highlighted the central role of the brain leptin-melanocortin pathway in controlling mammalian food intake, leading to the approval of setmelanotide as a drug for individuals with severe obesity due to specific genetic deficiencies. This research provides a template for drug discovery in complex disorders, showing how a single gene target can eventually lead to the development of an approved drug after 25 years of study.

MOLECULAR METABOLISM (2021)

Correction Multidisciplinary Sciences

Lkb1 suppresses amino acid-driven gluconeogenesis in the liver (vol 11, 6127, 2020)

Pierre-Alexandre Just, Sara Charawi, Raphael G. P. Denis, Mathilde Savall, Massire Traore, Marc Foretz, Sultan Bastu, Salimata Magassa, Nadia Senni, Pierre Sohier, Maud Wursmer, Mireille Vasseur-Cognet, Alain Schmitt, Morgane Le Gall, Marjorie Leduc, Francois Guillonneau, Jean-Pascal De Bandt, Patrick Mayeux, Beatrice Romagnolo, Serge Luquet, Pascale Bossard, Christine Perret

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice

Camilla Pramfalk, Osman Ahmed, Matteo Pedrelli, Mirko E. Minniti, Serge Luquet, Raphael Gp Denis, Maria Olin, Jennifer Hardfeldt, Lise-Lotte Vedin, Knut R. Steffensen, Mikael Ryden, Leanne Hodson, Mats Eriksson, Paolo Parini

Summary: This study reveals that depletion of the cholesterol ester synthesis enzyme Soat2 improves metabolic control in mice by partitioning lipids into secretory and oxidative pathways, reducing hepatic steatosis.

JOURNAL OF INTERNAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Identification of an endocannabinoid gut-brain vagal mechanism controlling food reward and energy homeostasis

Chloe Berland, Julien Castel, Romano Terrasi, Enrica Montalban, Ewout Foppen, Claire Martin, Giulio G. Muccioli, Serge Luquet, Giuseppe Gangarossa

Summary: This study explores the functional connection between the gut-brain axis and the reward and homeostatic brain structures using a physiologically relevant binge eating (BE) mouse model and multiscale in vivo approaches. The results reveal that compensatory adaptations in response to BE require the gut-to-brain axis, which relies on the permissive actions of peripheral endocannabinoids (eCBs) signaling through the vagus nerve. Inhibition of peripheral CB1 receptors increases hypothalamic activity, modulates metabolic efficiency, and dampens mesolimbic dopamine circuit activity, suppressing palatable eating. This study provides compelling evidence for a yet unappreciated physiological integrative mechanism involving peripheral eCBs and the vagus nerve in regulating homeostatic and reward-driven feeding.

MOLECULAR PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

Translational profiling of mouse dopaminoceptive neurons reveals region-specific gene expression, exon usage, and striatal prostaglandin E2 modulatory effects

Enrica Montalban, Albert Giralt, Lieng Taing, Evelien H. S. Schut, Laura F. Supiot, Laia Castell, Yuki Nakamura, Benoit de Pins, Assunta Pelosi, Laurence Goutebroze, Pola Tuduri, Wei Wang, Katrina Daila Neiburga, Letizia Vestito, Julien Castel, Serge Luquet, Angus C. Nairn, Denis Herve, Nathaniel Heintz, Claire Martin, Paul Greengard, Emmanuel Valjent, Frank J. Meye, Nicolas Gambardella, Jean-Pierre Roussarie, Jean-Antoine Girault

Summary: Forebrain dopamine-sensitive neurons play important roles in movement, action selection, motivation, and working memory. This study compares different populations of dopaminoceptive neurons and identifies differences in gene expression between them. Additionally, it reveals the potential role of prostaglandin E2 as a neuromodulator in the striatum and a potential therapeutic target.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

Hindbrain catecholaminergic inputs to the paraventricular thalamus scale feeding and metabolic efficiency in stress-related contexts

Clarisse Dumont, Guangping Li, Julien Castel, Serge Luquet, Giuseppe Gangarossa

Summary: The regulation of food intake and energy balance relies on the integration of signals monitoring nutritional, metabolic, cognitive, and emotional states. The paraventricular thalamus (PVT) is a central hub that may contribute to the regulation of feeding and homeostatic/allostatic processes. This study reveals the role of catecholaminergic (CA) inputs from the hindbrain to the PVT in scaling feeding and metabolic efficiency, as well as the modulation of downstream hypothalamic neuron activity.

JOURNAL OF PHYSIOLOGY-LONDON (2022)

Article Multidisciplinary Sciences

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury

Matthieu Leuillier, Thomas Duflot, Severine Menoret, Hind Messaoudi, Zoubir Djerada, Deborah Groussard, Raphael G. P. Denis, Laurence Chevalier, Ahmed Karoui, Baptiste Panthu, Pierre-Alain Thiebaut, Isabelle Schmitz-Afonso, Severine Nobis, Cynthia Campart, Tiphaine Henry, Camille Sautreuil, Serge H. Luquet, Olivia Beseme, Catherine Feliu, Helene Peyret, Lionel Nicol, Jean-Paul Henry, Sylvanie Renet, Paul Mulder, Debin Wan, Laurent Tesson, Jean-Marie Heslan, Angeline Duche, Sebastien Jacques, Frederic Ziegler, Valery Brunel, Gilles J. P. Rautureau, Christelle Monteil, Jean-Luc do Rego, Jean-Claude do Rego, Carlos Afonso, Bruce Hammock, Anne-Marie Madec, Florence Pinet, Vincent Richard, Ignacio Anegon, Christophe Guignabert, Christophe Morisseau, Jeremy Bellien

Summary: The physiological role of the N-terminal phosphatase activity (sEH-P) of soluble epoxide hydrolase (sEH-H) was investigated using CRISPR/Cas9 to generate a knock-in (KI) rat line lacking sEH-P activity. The study found that sEH-P KI rats exhibited decreased metabolism of lysophosphatidic acids, decreased weight and fat mass gain, and increased insulin sensitivity. Moreover, sEH-P KI rats showed increased lipolysis and enhanced energy expenditure, which potentiated brown adipose thermogenesis. Additionally, sEH-P KI rats fed a high-fat diet did not experience weight gain, fat mass accumulation, insulin resistance, or hepatic steatosis, and they also exhibited enhanced cardiac mitochondrial activity and protection against ischemia-reperfusion injury. Overall, the findings highlight the importance of sEH-P in energy and fat metabolism and its potential therapeutic significance in the management of obesity and cardiac complications.

JOURNAL OF ADVANCED RESEARCH (2023)

Article Cell Biology

Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions

Monica Imbernon, Chiara Saponaro, Hans Christian Cederberg Helms, Manon Duquenne, Daniela Fernandois, Eleonora Deligia, Raphael G. P. Denis, Daniela Herrera Moro Chao, Sowmyalakshmi Rasika, Bart Staels, Francois Pattou, Frank W. Pfrieger, Birger Brodin, Serge Luquet, Caroline Bonner, Vincent Prevot

Summary: Liraglutide is transported to the hypothalamus by specialized ependymoglial cells called tanycytes, bypassing the blood-brain barrier. Silencing GLP1R in tanycytes or inhibiting tanycytic transport blocks the effects of liraglutide on hypothalamic neurons and its anti-obesity effects.

CELL METABOLISM (2022)

Article Endocrinology & Metabolism

Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

Omar Al-Massadi, Paolo Parini, Johan Ferno, Serge Luquet, Mar Quinones

Summary: The growth hormone/insulin growth factor-1 axis plays a crucial role in regulating metabolism through its actions on peripheral tissues and the brain. It is involved in controlling food intake, energy expenditure, and glycemia, and interacts with the central nervous system. Dysregulation of this hepatic axis can lead to metabolic disorders such as obesity, type 2 diabetes, or liver disease. Possible therapeutic applications based on the components of this hepatic axis are discussed.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2022)

Article Cell Biology

Food Reward Alterations during Obesity Are Associated with Inflammation in the Striatum in Mice: Beneficial Effects of Akkermansia muciniphila

Sabrina J. P. Huwart, Alice de Wouters d'Oplinter, Marialetizia Rastelli, Matthias Van Hul, Willem M. de Vos, Serge Luquet, Patrice D. Cani, Amandine Everard

Summary: Reward system dysregulations during obesity are associated with inflammation and alterations in the blood-brain barrier. The gut microbiota Akkermansia muciniphila may improve reward behavior dysregulations in obesity by decreasing activation of inflammatory pathways and lipid-sensing ability in the striatum.
Article Cell Biology

Hypothalamic astrocytes control systemic glucose metabolism and energy balance

Daniela Herrera Moro Chao, Matthew K. Kirchner, Cuong Pham, Ewout Foppen, Raphael G. P. Denis, Julien Castel, Chloe Morel, Enrica Montalban, Rim Hassouna, Linh-Chi Bui, Justine Renault, Christine Mouffle, Cristina Garcia-Caceres, Matthias H. Tschop, Dongdong Li, Claire Martin, Javier E. Stern, Serge H. Luquet

Summary: The hypothalamic astrocytes play an important role in the control of systemic metabolism, and their activity is altered in obesity. Manipulation of astrocyte activity can affect neighboring neuron activity, autonomic outflow, glucose metabolism, and energy balance. This study suggests that targeting astrocytes may be a potential strategy for anti-obesity interventions.

CELL METABOLISM (2022)

Article Cell Biology

Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis

Wineke Bakker, Monica Imbernon, Casper Gravesen Salinas, Daniela Herrera Moro Chao, Rim Hassouna, Chloe Morel, Claire Martin, Caroline Leger, Raphael G. P. Denis, Julien Castel, Andreas Peter, Martin Heni, Walter Maetzler, Heidi Solvang Nielsen, Manon Duquenne, Markus Schwaninger, Sofia Lundh, Wouter Frederic Johan Hogendorf, Giuseppe Gangarossa, Anna Secher, Jacob Hecksher-Sorensen, Thomas Askov Pedersen, Vincent Prevot, Serge Luquet

Summary: A study found that insulin-induced hypoglycemia enhances the entry of GLP-1R agonists into the brain, leading to increased whole-body fat oxidation. This phenomenon relies partially on the release of tanycyctic vascular endothelial growth factor A, which is selectively impaired after exposure to a high-calorie diet. In humans, low blood glucose also enhances the passage of insulin into the brain through the blood-brain barrier. Therefore, preventing hyperglycemia is crucial for fully harnessing the benefits of GLP-1R agonists in the brain.

CELL REPORTS (2022)

暂无数据